Paragon Events is at it again- this time managing a first-of-its-kind life sciences conference. BioFlorida, Inc. hosted its first-ever Latin America & Caribbean Life Sciences Conference in Miami on March 27-28.
BioFlorida is the state affiliate of the U.S. national Biotechnology Industry Organization (BIO).
The conference featured premier educational sessions and presentations from industry leaders and experts. Programming covered opportunities and potential obstacles for cross-region collaborations, addressing research, clinical and commercial strategies, economic incentives, the current regulatory climate, and financing options.
“This conference recognizes the key role Florida plays in setting the foundation for greater scientific and commercial collaboration across the Americas,” said Gregory A. Nelson, conference chair and partner at Novak Druce Connolly Bove + Quigg LLP. “Historically, many areas such as trade and manufacturing, have benefited from this connection. Now, we are bringing the spotlight to the life sciences.
“This conference is an opportunity for participants to meet in a single location with the goal to optimize their successes and foster the growth of the pharmaceutical, biotech and medical device industries,” said Nancy K. Bryan, president and CEO, BioFlorida. “The program is comprehensive and features an impressive line-up of speakers from the U.S. and Latin America, including high-ranked corporate executives, public officials, regulatory experts, and investment and economic development professionals.”
KEYNOTE AND FEATURED SPEAKER LINE-UP: Gabriela Gebrin Cezar, Senior Director & Head, External R&D at Innovation and Brazil, Latin America & South Africa Worldwide Research and Development, Pfizer; James Hogan, President, Medtronic Latin America and VP, Medtronic, Inc.; Miguel Ángel Margáin, Director General of the Mexican Institute of Industrial Property; Gray Swoope, Secretary of Commerce, President & CEO, Enterprise Florida, Inc.; Mark B. Rosenberg, PhD, President of Florida International University and Lieutenant Governor Carlos Lopez-Cantera (invited).
The conference featured six panel discussions moderated by industry experts:
• University & Research Organizations: Capabilities & Collaborations with Latin America - Past, Present and Future
• Financing Options for Emerging & Established Companies
• Research and Commercial: Successes and Collaborations
• Economic Development and Incentive Opportunities
• Intellectual Property
• Regulatory Framework
Attendees were able to connect via the BioFlorida Partnering system before the event and then for six weeks after the conference.
ABOUT BIOFLORIDA
BioFlorida (BioFlorida.com) is the voice of Florida’s life sciences industry, representing more than 3,000 companies and research organizations in the biotechnology, pharmaceuticals, medical devices, and bio-agriculture fields that employ nearly 84,000 Floridians. BioFlorida’s member-driven initiatives provide a strong business climate for development and production of innovative technologies and products that improve lives and promote economic benefits to the state.
0 comments:
Post a Comment